Healthy Skepticism Library item: 6474

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: report

van Maaren PJM, van Mil JWF, Hardon AP, Haaijer-Ruskamp FM, Dukes MNG
Dutch drugs in developing countries
Groningen: Styx Publications 1994

Abstract:

This report assesses the nature and extent of the problems involved in the export of drugs from the Netherlands to developing countries. Of the 161 drugs that could be evaluated (contents and data sheet being available), 42% should be considered problem drugs according to the criteria of this report. Only 5% of the samples tested showed a problem concerning the substance, most of the problems were inconsistencies in listing side effects (14.8%), contraindications (12.2%) and inconsistent warnings (9.2%).

Keywords:
*analytic survey/Netherlands/developing countries/safety & risk information/quality of information/EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES